Neuroinflammatory genes associated with post-traumatic stress disorder: Implications for comorbidity

Psychiatric Genetics

Volumn 27, Issue 1, 2017, Pages 1-16

  Zass, Lyndon J ^a,b   Hart, Stephanie A ^a   Seedat, Soraya ^b   Hemmings, Sian M J ^b   Malan Müller, Stefanie ^b  

^a Division of Molecular Biology and Human Genetics ^*  (South Africa)

^b UNIVERSITY OF STELLENBOSCH   (South Africa)

Author keywords

C reactive protein; Comorbidity; Cytokines; Gene expression; Glucocorticoid receptor; Inflammation; Neuroinflammation; Nuclear factor ; Post traumatic stress disorder; Single nucleotide polymorphisms

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; FK 506 BINDING PROTEIN; GLUCOCORTICOID RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; STAT5B PROTEIN;

ANXIETY; ANXIETY DISORDER; CHRONIC INFLAMMATION; CHRONIC STRESS; COMORBIDITY; DEPRESSION; DISEASE ASSOCIATION; GENETIC ASSOCIATION; HUMAN; METABOLIC SYNDROME X; NERVOUS SYSTEM INFLAMMATION; NEUROLOGIC DISEASE; PLEIOTROPY; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; REVIEW; FEAR; GENETICS; IMMUNOLOGY; IMMUNOMODULATION; INFLAMMATION; MENTAL STRESS; METABOLISM; PSYCHOLOGY; RISK FACTOR;

COMORBIDITY; FEAR; HUMANS; INFLAMMATION; NEUROIMMUNOMODULATION; RISK FACTORS; STRESS DISORDERS, POST-TRAUMATIC; STRESS, PSYCHOLOGICAL;

EID: 84987920179     PISSN: 09558829     EISSN: 14735873     Source Type: Journal    
DOI: 10.1097/YPG.0000000000000143     Document Type: Review

References (221)

1. Abd El-Aziz TA, Mohamed RH (2013). Human C-reactive protein gene polymorphism and metabolic syndrome are associated with premature coronary artery disease. Gene 532:216-221.
2. Aguilera G (2011). HPA axis responsiveness to stress: implications for healthy aging. Exp Gerontol 46:90-95.
3. Almeida OP, Norman PE, Allcock R, van Bockxmeer F, Hankey GJ, Jamrozik K, Flicker L (2009). Polymorphisms of the CRP gene inhibit inflammatory response and increase susceptibility to depression: the Health in Men Study. Int J Epidemiol 38:1049-1059.
4. American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Arlington, VA: American Psychiatric Publishing.
5. Ancelin ML, Farré A, Carriére I, Ritchie K, Chaudieu I, Ryan J (2015). C-reactive protein gene variants: independent association with late-life depression and circulating protein levels. Transl Psychiatry 5:e499.
6. Arosio B, Trabattoni D, Galimberti L, Bucciarelli P, Fasano F, Calabresi C, et al. (2004). Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease. Neurobiol Aging 25:1009-1015.
7. Bachmann AW, Sedgley TL, Jackson RV, Gibson JN, Young RM, Torpy DJ (2005). Glucocorticoid receptor polymorphisms and post-traumatic stress disorder. Psychoneuroendocrinology 30:297-306.
8. Bagli M, Papassotiropoulos A, Knapp M, Jessen F, Luise Rao M, MaierW, Heun R (2000). Association between an interleukin-6 promoter and 3' flanking region haplotype and reduced Alzheimer's disease risk in a German population. Neurosci Lett 283:109-112.
9. Bam M, Yang X, Zhou J, Ginsberg JP, Leyden Q, Nagarkatti PS, Nagarkatti M (2016). Evidence for epigenetic regulation of pro-inflammatory cytokines, interleukin-12 and interferon gamma, in peripheral blood mononuclear cells from PTSD patients. J Neuroimmune Pharmacol 11:168-181.
10. Bankoski A, Harris TB, McClain JJ, Brychta RJ, Caserotti P, Chen KY, et al. (2011). Sedentary activity associated with metabolic syndrome independent of physical activity. Diabetes Care 34:497-503.
11. Barcia C, Ros CM, Annese V, Gómez A, Ros-Bernal F, Aguado-Yera D, et al. (2011). IFN-? signaling, with the synergistic contribution of TNF-A, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease. Cell Death Dis 2:e142.
12. Beumer W, Drexhage RC, de Wit H, Versnel MA, Drexhage HA, Cohen D (2012). Increased level of serum cytokines, chemokines and adipokines in patients with schizophrenia is associated with disease and metabolic syndrome. Psychoneuroendocrinology 37:1901-1911.
13. Bhojak TJ, DeKosky ST, Ganguli M, Kamboh MI (2000). Genetic polymorphisms in the cathespin D and interleukin-6 genes and the risk of Alzheimer's disease. Neurosci Lett 288:21-24.
14. Bialecka M, Klodowska-Duda G, Kurzawski M, Slawek J, Gorzkowska A, Opala G, et al. (2008). Interleukin-10 (IL10) and tumor necrosis factor alpha (TNF) gene polymorphisms in Parkinson's disease patients. Parkinsonism Relat Disord 14:636-640.
15. Bienenstock J, Kunze W, Forsythe P (2015). Microbiota and the gut-brain axis. Nutr Rev 73:28-31.
16. Bierhaus A,Wolf J, Andrassy M, Rohleder N, Humpert PM, Petrov D, et al. (2003). A mechanism converting psychosocial stress into mononuclear cell activation. Proc Natl Acad Sci USA 100:1920-1925.
17. Binder EB, Bradley RG, Liu W, Epstein MP, Deveau TC, Mercer KB, et al. (2008). Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA 299:1291-1305.
18. Bitsika V, Sharpley CF, Sweeney JA, McFarlane JR (2014). HPA and SAM axis responses as correlates of self-vs parental ratings of anxiety in boys with an autistic disorder. Physiol Behav 127:1-7.
19. Boin F, Zanardini R, Pioli R, Altamura CA, Maes M, Gennarelli M (2001). Association between-G308A tumor necrosis factor alpha gene polymorphism and schizophrenia. Mol Psychiatry 6:79-82.
20. Borkowska P, Kucia K, Rzezniczek S, Paul-Samojedny M, Kowalczyk M, Owczarek A, et al. (2011). Interleukin-1beta promoter (-31 T/C and-511C/T) polymorphisms in major recurrent depression. J Mol Neurosci 44:12-16.
21. Boscarino JA, Erlich PM, Hoffman SN, Rukstalis M, Stewart WF (2011). Association of FKBP5, COMT and CHRNA5 polymorphisms with PTSD among outpatients at risk for PTSD. Psychiatry Res 188:173-174.
22. Brady KT, Killeen TK, Brewerton T, Lucerini S (2000). Comorbidity of psychiatric disorders and posttraumatic stress disorder. J Clin Psychiatry 61 (Suppl 7): 22-32.
23. Breen MS, Maihofer AX, Glatt SJ, Tylee DS, Chandler SD, Tsuang MT, et al. (2015). Gene networks specific for innate immunity define post-traumatic stress disorder. Mol Psychiatry 20:1538-1545.
24. Buckley PF, Miller BJ, Lehrer DS, Castle DJ (2009). Psychiatric comorbidities and schizophrenia. Schizophr Bull 35:383-402.
25. Burriss L, Ayers E, Ginsberg J, Powell DA (2008). Learning and memory impairment in PTSD: relationship to depression. Depress Anxiety 25:149-157.
26. Cappi C, Muniz RK, Sampaio AS, Cordeiro Q, Brentani H, Palácios SA, et al. (2012). Association study between functional polymorphisms in the TNFalpha gene and obsessive-compulsive disorder. Arq Neuropsiquiatr 70:87-90.
27. Capurso C, Solfrizzi V, D'Introno A, Colacicco AM, Capurso SA, Capurso A, Panza F (2004). Interleukin 6-174G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe. Exp Gerontol 39:1567-1573.
28. Carvalho LA, Bergink V, Sumaski L, Wijkhuijs J, Hoogendijk WJ, Birkenhager TK, Drexhage HA (2014). Inflammatory activation is associated with a reduced glucocorticoid receptor alpha/beta expression ratio in monocytes of inpatients with melancholic major depressive disorder. Transl Psychiatry 4:e344.
29. Cattaneo A, Gennarelli M, Uher R, Breen G, Farmer A, Aitchison KJ, et al. (2013). Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets'. Neuropsychopharmacol 38:377-385.
30. Cerri AP, Arosio B, Viazzoli C, Confalonieri R, Vergani C, Annoni G (2010). The-308 (G/A) single nucleotide polymorphism in the TNF-Alpha gene and the risk of major depression in the elderly. Int J Geriatr Psychiatry 25:219-223.
31. Ceulemans S, de Zutter S, Heyrman L, Norrback KF, Nordin A, Nilsson LG, et al. (2011). Evidence for the involvement of the glucocorticoid receptor gene in bipolar disorder in an isolated northern Swedish population. Bipolar Disord 13:614-623.
32. Chang SH, Chiang SY, Chiu CC, Tsai CC, Tsai HH, Huang CY, et al. (2011). Expression of anti-cardiolipin antibodies and inflammatory associated factors in patients with schizophrenia. Psychiatry Res 187:341-346.
33. Chao CC, Hu S, Molitor TW, Shaskan EG, Peterson PK (1992). Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J Immunol 149:2736-2741.
34. Chassaing B, Gewirtz AT (2014). Gut microbiota, low-grade inflammation, and metabolic syndrome. Toxicol Pathol 42:49-53.
35. Chrousos GP (2009). Stress and disorders of the stress system. Nat Rev Endocrinol 5:374.
36. Clerici M, Arosio B, Mundo E, Cattaneo E, Pozzoli S, Dell'osso B, et al. (2009). Cytokine polymorphisms in the pathophysiology of mood disorders. CNS Spectr 14:419-425.
37. Cloitre M, Garvert DW, Weiss B, Carlson EB, Bryant RA (2014). Distinguishing PTSD, complex PTSD, and borderline personality disorder: a latent class analysis. Eur J Psychotraumatol 5. doi: 10.3402/ejpt.v5.25097.
38. Cohen H, Kozlovsky N, Matar MA, Zohar J, Kaplan Z (2011). The characteristic long-term upregulation of hippocampal NF-?B complex in PTSD-like behavioral stress response is normalized by high-dose corticosterone and pyrrolidine dithiocarbamate administered immediately after exposure. Neuropsychopharmacology 36:2286-2302.
39. Cryan JF, O'Mahony SM (2011). The microbiome-gut-brain axis: from bowel to behavior. Neurogastroenterol Motil 23:187-192.
40. De Pablos RM, Herrera AJ, Espinosa-Oliva AM, Sarmiento M, Muñoz MF, Machado A, Venero JL (2014). Chronic stress enhances microglia activation and exacerbates death of nigral dopaminergic neurons under conditions of inflammation. J Neuroinflammation 11:34.
41. De Pergola G, Giorgino F, Benigno R, Guida P, Giorgino R (2008). Independent influence of insulin, catecholamines, and thyroid hormones on metabolic syndrome. Obesity (Silver Spring) 16:2405-2411.
42. Diaz Padilla N, Bleeker WK, Lubbers Y, Rigter GM, van Mierlo GJ, Daha MR, Hack CE (2003). Rat C-reactive protein activates the autologous complement system. Immunology 109:564-571.
43. Drexhage RC, van der Heul-Nieuwenhuijsen L, Padmos RC, van Beveren N, Cohen D, Versnel MA, et al. (2010). Inflammatory gene expression in monocytes of patients with schizophrenia: overlap and difference with bipolar disorder. A study in naturalistically treated patients. Int J Neuropsychopharmacol 13:1369-1381.
44. Duivis HE, Vogelzangs N, Kupper N, de Jonge P, Penninx BW., 2013). Differential association of somatic and cognitive symptoms of depression and anxiety with inflammation: findings from the Netherlands Study of Depression and Anxiety (NESDA). Psychoneuroendocrinology 38:1573-1585.
45. Ehring T, Ehlers A, Cleare AJ, Glucksman E (2008). Do acute psychological and psychobiological responses to trauma predict subsequent symptom severities of PTSD and depression? Psychiatry Res 161:67-75.
46. Elenkov IJ (2008). Neurohormonal-cytokine interactions: implications for inflammation, common human diseases and well-being. Neurochem Int 52:40-51.
47. Elenkov IJ, Iezzoni DG, Daly A, Harris AG, Chrousos GP (2005). Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation 12:255-269.
48. Eraly SA, Nievergelt CM, Maihofer AX, Barkauskas DA, Biswas N, Agorastos A, et al., Marine Resiliency Study Team (2014). Assessment of plasma C-reactive protein as a biomarker of posttraumatic stress disorder risk. JAMA Psychiatry 71:423-431.
49. Esser N, Legrand-Poels S, Piette J, Scheen AJ, Paquot N (2014). Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract 105:141-150.
50. Fagiolini A, Goracci A (2009). The effects of undertreated chronic medical illnesses in patients with severe mental disorders. J Clin Psychiatry 70 (Suppl 3):22-29.
51. Faltraco F, Bürger K, Zill P, Teipel SJ, Möller H-J, Hampel H, et al. (2003). Interleukin-6-174G/C promoter gene polymorphism c allele reduces Alzheimer's disease risk. J Am Geriatr Soc 51:578-579.
52. Filakovic P, Petek Eric A, Radanovic-Grguric L (2012). Metabolic syndrome and psychotropic medications. Med Glas (Zenica) 9:180-188.
53. Foldager L, Köhler O, Steffensen R, Thiel S, Kristensen AS, Jensenius JC, Mors O (2014). Bipolar and panic disorders may be associated with hereditary defects in the innate immune system. J Affect Disord 164:148-154.
54. Foley DL, Morley KI, Madden PA, Heath AC, Whitfield JB, Martin NG (2010). Major depression and the metabolic syndrome. Twin Res Hum Genet 13:347-358.
55. Fröhlich M, Imhof A, Berg G, Hutchinson WL, Pepys MB, Boeing H, et al. (2000). Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care 23:1835-1839.
56. Furtado M, Katzman MA (2015). Neuroinflammatory pathways in anxiety, posttraumatic stress, and obsessive compulsive disorders. Psychiatry Res 229:37-48.
57. Galecka E, Szemraj J, Bienkiewicz M, Majsterek I, Przybylowska-Sygut K, Galecki P, Lewinski A (2013). Single nucleotide polymorphisms of NR3C1 gene and recurrent depressive disorder in population of Poland. Mol Biol Rep 40:1693-1699.
58. García Bueno B, Caso JR, Madrigal JL, Leza JC (2016). Innate immune receptor toll-like receptor 4 signalling in neuropsychiatric diseases. Neurosci Biobehav Rev 64:134-147.
59. Gardai SJ, Mao W, Schüle B, Babcock M, Schoebel S, Lorenzana C, et al. (2013). Elevated alpha-synuclein impairs innate immune cell function and provides a potential peripheral biomarker for Parkinson's disease. PLoS One 8:e71634.
60. Gariup M, Gonzalez A, Lázaro L, Torres F, Serra-Pagés C, Morer A (2015). IL-8 and the innate immunity as biomarkers in acute child and adolescent psychopathology. Psychoneuroendocrinology 62:233-242.
61. Gimeno D, Kivimäki M, Brunner EJ, Elovainio M, de Vogli R, Steptoe A, et al. (2009). Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychol Med 39:413-423.
62. Ginzburg K, Ein-Dor T, Solomon Z (2010). Comorbidity of posttraumatic stress disorder, anxiety and depression: a 20-year longitudinal study of war veterans. J Affect Disord 123:249-257.
63. Glatt SJ, Tylee DS, Chandler SD, Pazol J, Nievergelt CM, Woelk CH, et al., Marine Resiliency Study Investigators (2013). Blood-based gene-expression predictors of PTSD risk and resilience among deployed marines: a pilot study. Am J Med Genet B Neuropsychiatr Genet 162B:313-326.
64. Gola H, Engler A, Morath J, Adenauer H, Elbert T, Kolassa IT, Engler H (2014). Reduced peripheral expression of the glucocorticoid receptor a isoform in individuals with posttraumatic stress disorder: a cumulative effect of trauma burden. PLoS One 9:e86333.
65. Gotovac K, Sabioncello A, Rabatic S, Berki T, Dekaris D (2003). Flow cytometric determination of glucocorticoid receptor (GCR) expression in lymphocyte subpopulations: lower quantity of GCR in patients with post-traumatic stress disorder (PTSD). Clin Exp Immunol 131:335-339.
66. Gravius A, Pietraszek M, Dekundy A, Danysz W (2010). Metabotropic glutamate receptors as therapeutic targets for cognitive disorders. Curr Top Med Chem 10:187-206.
67. Grossman F, Potter WZ (1999). Catecholamines in depression: a cumulative study of urinary norepinephrine and its major metabolites in unipolar and bipolar depressed patients versus healthy volunteers at the NIMH. Psychiatry Res 87:21-27.
68. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. (2005). Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735-2752.
69. Guardado P, Olivera A, Rusch HL, Roy M, Martin C, Lejbman N, et al. (2016). Altered gene expression of the innate immune, neuroendocrine, and nuclear factor-kappa B (NF-?B) systems is associated with posttraumatic stress disorder in military personnel. J Anxiety Disord 38:9-20.
70. Gupta V, Gupta A, Jafar T, Gupta V, Agrawal S, Srivastava N, et al. (2012). Association of TNF-A promoter gene G-308 A polymorphism with metabolic syndrome, insulin resistance, serum TNF-A and leptin levels in Indian adult women. Cytokine 57:32-36.
71. Haarman BC, Riemersma-Van der Lek RF, Burger H, Netkova M, Drexhage RC, Bootsman F, et al. (2014). Relationship between clinical features and inflammation-related monocyte gene expression in bipolar disorder-towards a better understanding of psychoimmunological interactions. Bipolar Disord 16:137-150.
72. Håkansson A, Westberg L, Nilsson S, Buervenich S, Carmine A, Holmberg B, et al. (2005). Investigation of genes coding for inflammatory components in Parkinson's disease. Mov Disord 20:569-573.
73. Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, Ettinger WH Jr., et al. (1999). Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 106:506-512.
74. Hauer D, Weis F, Papassotiropoulos A, Schmoeckel M, Beiras-Fernandez A, Lieke J, et al. (2011). Relationship of a common polymorphism of the glucocorticoid receptor gene to traumatic memories and posttraumatic stress disorder in patients after intensive care therapy. Crit Care Med 39:643-650.
75. Heppner PS, Crawford EF, Haji UA, Afari N, Hauger RL, Dashevsky BA, et al. (2009). The association of posttraumatic stress disorder and metabolic syndrome: a study of increased health risk in veterans. BMC Med 7:1.
76. Hermoso MA, Cidlowski JA (2003). Putting the brake on inflammatory responses: the role of glucocorticoids. IUBMB Life 55:497-504.
77. Ho PS, Yeh YW, Huang SY, Liang CS (2015). A shift toward T helper 2 responses and an increase in modulators of innate immunity in depressed patients treated with escitalopram. Psychoneuroendocrinology 53:246-255.
78. Hoskins M, Pearce J, Bethell A, Dankova L, Barbui C, Tol WA, et al. (2015). Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-Analysis. Br J Psychiatry 206:93-100.
79. Hovhannisyan LP, Mkrtchyan GM, Sukiasian SH, Boyajyan AS (2010). Alterations in the complement cascade in post-traumatic stress disorder. Allergy Asthma Clin Immunol 6:3.
80. Hung YY, Kang HY, Huang KW, Huang TL (2014). Association between toll-like receptors expression and major depressive disorder. Psychiatry Res 220:283-286.
81. Hwang JP, Tsai SJ, Hong CJ, Yang CH, Hsu CD, Liou YJ (2009). Interleukin-1 beta-511C/T genetic polymorphism is associated with age of onset of geriatric depression. Neuromolecular Med 11:322-327.
82. Iacob E, Light KC, Tadler SC, Weeks HR, White AT, Hughen RW, et al. (2013). Dysregulation of leukocyte gene expression in women with medicationrefractory depression versus healthy non-depressed controls. BMC Psychiatry 13:273.
83. Ingelsson E, Hulthe J, Lind L (2008). Inflammatory markers in relation to insulin resistance and the metabolic syndrome. Eur J Clin Invest 38:502-509.
84. Janelidze S, Suchankova P, Ekman A, Erhardt S, Sellgren C, Samuelsson M, et al. (2015). Low IL-8 is associated with anxiety in suicidal patients: genetic variation and decreased protein levels. Acta Psychiatr Scand 131:269-278.
85. Johnson JD, Campisi J, Sharkey CM, Kennedy SL, Nickerson M, Greenwood BN, Fleshner M (2005). Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines. Neuroscience 135: 1295-1307.
86. Juruena MF (2014). Early-life stress and HPA axis trigger recurrent adulthood depression. Epilepsy Behav 38:148-159.
87. Kahl KG, Kruse N, Faller H, Weiss H, Rieckmann P (2002). Expression of tumor necrosis factor-Alpha and interferon-gamma mRNA in blood cells correlates with depression scores during an acute attack in patients with multiple sclerosis. Psychoneuroendocrinology 27:671-681.
88. Kang WS, Park JK, Lee SM, Kim SK, Park HJ, Kim JW (2013). Association between genetic polymorphisms of toll-like receptor 2 (TLR2) and schizophrenia in the Korean population. Gene 526:182-186.
89. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB (1995). Posttraumatic stress disorder in the national comorbidity survey. Arch Gen Psychiatry 52:1048-1060.
90. Kessler RC, Aguilar-Gaxiola S, Alonso J, Chatterji S, Lee S, Ormel J, et al. (2009). The global burden of mental disorders: an update from the WHO World Mental Health (WMH) surveys. Epidemiol Psichiatr Soc 18:23-33.
91. Kim HJ, Eom CY, Kwon J, Joo J, Lee S, Nah SS, et al. (2012a). Roles of interferongamma and its target genes in schizophrenia: Proteomics-based reverse genetics from mouse to human. Proteomics 12:1815-1829.
92. Kim JM, Stewart R, Kim SW, Shin IS, Kim JT, Park MS, et al. (2012b). Associations of cytokine gene polymorphisms with post-stroke depression. World J Biol Psychiatry 13:579-587.
93. Kioussis D, Pachnis V (2009). Immune and nervous systems: more than just a superficial similarity? Immunity 31:705-710.
94. Koenen KC, Saxe G, Purcell S, Smoller JW, Bartholomew D, Miller A, et al. (2005). Polymorphisms in FKBP5 are associated with peritraumatic dissociation in medically injured children. Mol Psychiatry 10:1058-1059.
95. Koenen KC, Fu QJ, Ertel K, Lyons MJ, Eisen SA, True WR, et al. (2008). Common genetic liability to major depression and posttraumatic stress disorder in men. J Affect Disord 105:109-115.
96. Kok EH, Alanne-Kinnunen M, Isotalo K, Luoto T, Haikonen S, Goebeler S, et al. (2011). CRP gene variation affects early development of Alzheimer's diseaserelated plaques. J Neuroinflammation 8:96.
97. Kolev MV, Ruseva MM, Harris CL, Morgan BP, Donev RM (2009). Implication of complement system and its regulators in Alzheimer's disease. Curr Neuropharmacol 7:1-8.
98. Koponen H, Jokelainen J, Keinänen-Kiukaanniemi S, Kumpusalo E, Vanhala M (2008). Metabolic syndrome predisposes to depressive symptoms: a population-based 7-year follow-up study. J Clin Psychiatry 69:178-182.
99. Krishnamurthy P, Romagni P, Torvik S, Gold PW, Charney DS, Detera-Wadleigh S, Cizza G, P.O.W.E.R. (Premenopausal, Osteoporosis Women, Alendronate, Depression) Study Group (2008). Glucocorticoid receptor gene polymorphisms in premenopausal women with major depression. Horm Metab Res 40:194-198.
100. Lacy P, Stow JL (2011). Cytokine release from innate immune cells: association with diverse membrane trafficking pathways. Blood 118:9-18.
101. Lasic D, Bevanda M, Bošnjak N, Uglešic B, Glavina T, Franic T (2014). Metabolic syndrome and inflammation markers in patients with schizophrenia and recurrent depressive disorder. Psychiatr Danub 26:214-219.
102. Lavebratt C, Aberg E, Sjöholm LK, Forsell Y (2010). Variations in FKBP5 and BDNF genes are suggestively associated with depression in a Swedish population-based cohort. J Affect Disord 125:249-255.
103. Levy-Gigi E, Szabó C, Kelemen O, Kéri S (2013). Association among clinical response, hippocampal volume, and FKBP5 gene expression in individuals with posttraumatic stress disorder receiving cognitive behavioral therapy. Biol Psychiatry 74:793-800.
104. Lewis KL, Grenyer BFS (2009). Borderline Personality or Complex Posttraumatic Stress Disorder? An Update on the Controversy. Harv Rev Psychiatry 17:322-328.
105. Li Y, Liu L, Barger SW, Griffin WS (2003). Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway. J Neurosci 23:1605-1611.
106. Lian Y, Xiao J, Wang Q, Ning L, Guan S, Ge H, et al. (2014). The relationship between glucocorticoid receptor polymorphisms, stressful life events, social support, and post-traumatic stress disorder. BMC Psychiatry 14:232.
107. Liberzon I, López JF, Flagel SB, Vázquez DM, Young EA (1999). Differential regulation of hippocampal glucocorticoid receptors mRNA and fast feedback: relevance to post-traumatic stress disorder. J Neuroendocrinol 11:11-17.
108. Licastro F, Grimaldi LM, Bonafé M, Martina C, Olivieri F, Cavallone L, et al. (2003). Interleukin-6 gene alleles affect the risk of Alzheimer's disease and levels of the cytokine in blood and brain. Neurobiol Aging 24:921-926.
109. Litvinova L, Atochin D, Vasilenko M, Fattakhov N, Zatolokin P, Vaysbeyn I, Kirienkova E (2014). Role of adiponectin and proinflammatory gene expression in adipose tissue chronic inflammation in women with metabolic syndrome. Diabetol Metab Syndr 6:137.
110. Liu B, Hong JS (2003). Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther 304:1-7.
111. Liu HC, Yang YY, Chou YM, Chen KP, Shen WW, Leu SJ (2004). Immunologic variables in acute mania of bipolar disorder. J Neuroimmunol 150:116-122.
112. Liu Z, Tang Q, Wen J, Tang Y, Huang D, Huang Y, et al. (2016). Elevated serum complement factors 3 and 4 are strong inflammatory markers of the metabolic syndrome development: a longitudinal cohort study. Sci Rep 6:18713.
113. Logue MW, Baldwin C, Guffanti G, Melista E, Wolf EJ, Reardon AF, et al. (2013). A genome-wide association study of post-traumatic stress disorder identifies the retinoid-related orphan receptor alpha (RORA) gene as a significant risk locus. Mol Psychiatry 18:937-942.
114. Lott SA, Burghardt PR, Burghardt KJ, Bly MJ, Grove TB, Ellingrod VL (2013). The influence of metabolic syndrome, physical activity and genotype on catechol-O-methyl transferase promoter-region methylation in schizophrenia. Pharmacogenomics J 13:264-271.
115. Luterman JD, Haroutunian V, Yemul S, Ho L, Purohit D, Aisen PS, et al. (2000). Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia. Arch Neurol 57:1153-1160.
116. Malan S. (2013). Molecular mechanisms of D-cycloserine in a fear extinction posttraumatic stress disorder (PTSD) animal model (Unpublished doctoral dissertation). Stellenbosch University, South Africa.
117. Markiewski MM, Lambris JD (2007). The role of complement in inflammatory diseases from behind the scenes into the spotlight. Am J Pathol 171:715-727.
118. Matic G, Milutinovic DV, Nestorov J, Elakovic I, Jovanovic SM, Perišic T, et al. (2013). Lymphocyte glucocorticoid receptor expression level and hormonebinding properties differ between war trauma-exposed men with and without PTSD. Prog Neuropsychopharmacol Biol Psychiatry 43:238-245.
119. Mayilyan KR, Weinberger DR, Sim RB (2008). The complement system in schizophrenia. Drug News Perspect 21:200-210.
120. McEwen BS (2002). Sex, stress and the hippocampus: allostasis, allostatic load and the aging process. Neurobiol Aging 23:921-939.
121. Meffert MK, Baltimore D (2005). Physiological functions for brain NF-kappaB. Trends Neurosci 28:37-43.
122. Mehta D, Gonik M, Klengel T, Rex-Haffner M, Menke A, Rubel J, et al. (2011). Using polymorphisms in FKBP5 to define biologically distinct subtypes of posttraumatic stress disorder: evidence from endocrine and gene expression studies. Arch Gen Psychiatry 68:901-910.
123. Melas PA, Wei Y, Wong CC, Sjöholm LK, Aberg E, Mill J, et al. (2013). Genetic and epigenetic associations of MAOA and NR3C1 with depression and childhood adversities. Int J Neuropsychopharmacol 16:1513-1528.
124. Menke A, Klengel T, Rubel J, Brückl T, Pfister H, Lucae S, et al. (2013). Genetic variation in FKBP5 associated with the extent of stress hormone dysregulation in major depression. Genes Brain Behav 12:289-296.
125. Miaskowski C, Cataldo JK, Baggott CR, West C, Dunn LB, Dhruva A, et al. (2015). Cytokine gene variations associated with trait and state anxiety in oncology patients and their family caregivers. Support Care Cancer 23:953-965.
126. Michopoulos V, Rothbaum AO, Jovanovic T, Almli LM, Bradley B, Rothbaum BO, et al. (2015). Association of CRP genetic variation and CRP level with elevated PTSD symptoms and physiological responses in a civilian population with high levels of trauma. Am J Psychiatry 172:353-362.
127. Minelli A, Maffioletti E, Cloninger CR, Magri C, Sartori R, Bortolomasi M, et al. (2013). Role of allelic variants of FK506-binding protein 51 (FKBP5) gene in the development of anxiety disorders. Depress Anxiety 30:1170-1176.
128. Mirhafez SR, Pasdar A, Avan A, Esmaily H, Moezzi A, Mohebati M, et al. (2015). Cytokine and growth factor profiling in patients with the metabolic syndrome. Br J Nutr 113:1911-1919.
129. Molina-Holgado E, Molina-Holgado F (2010). Mending the broken brain: neuroimmune interactions in neurogenesis. J Neurochem 114:1277-1290.
130. Morimoto K, Horio J, Satoh H, Sue L, Beach T, Arita S, et al. (2011). Expression profiles of cytokines in the brains of Alzheimer's disease (AD) patients compared to the brains of non-demented patients with and without increasing AD pathology. J Alzheimers Dis 25:59-76.
131. Mostafavi S, Battle A, Zhu X, Potash JB,Weissman MM, Shi J, et al. (2014). Type I interferon signaling genes in recurrent major depression: increased expression detected by whole-blood RNA sequencing. Mol Psychiatry 19:1267-1274.
132. Naviaux RK (2014). Metabolic features of the cell danger response. Mitochondrion 16:7-17.
133. Neylan TC, Lenoci M, Rothlind J, Metzler TJ, Schuff N, Du AT, et al. (2004). Attention, learning, and memory in posttraumatic stress disorder. J Trauma Stress 17:41-46.
134. Ng F, Berk M, Dean O, Bush AI (2008). Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol 11:851-876.
135. Nuti A, Ceravolo R, Piccinni A, Dell'Agnello G, Bellini G, Gambaccini G, et al. (2004). Psychiatric comorbidity in a population of Parkinson's disease patients. Eur J Neurol Off J Eur Fed Neurol Soc 11:315-320.
136. O'Donovan A, Sun B, Cole S, Rempel H, Lenoci M, Pulliam L, Neylan T (2011). Transcriptional control of monocyte gene expression in post-traumatic stress disorder. Dis Markers 30:123-132.
137. Oganesyan LP, Mkrtchyan GM, Sukiasyan SH, Boyajyan AS (2009). Classic and alternative complement cascades in post-traumatic stress disorder. Bull Exp Biol Med 148:859-861.
138. Opstad TB, Pettersen AA, Arnesen H, Seljeflot I (2011). Circulating levels of IL-18 are significantly influenced by the IL-18 + 183 A/G polymorphism in coronary artery disease patients with diabetes type 2 and the metabolic syndrome: an observational study. Cardiovasc Diabetol 10:110.
139. Otto MW, Perlman CA, Wernicke R, Reese HE, Bauer MS, Pollack MH (2004). Posttraumatic stress disorder in patients with bipolar disorder: a review of prevalence, correlates, and treatment strategies. Bipolar Disord 6:470-479.
140. Paaby AB, Rockman MV (2013). The many faces of pleiotropy. Trends Genet 29:66-73.
141. Padmos RC, Hillegers MH, Knijff EM, Vonk R, Bouvy A, Staal FJ, et al. (2008). A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. Arch Gen Psychiatry 65:395-407.
142. Pan A, Keum N, Okereke OI, Sun Q, Kivimaki M, Rubin RR, Hu FB (2012). Bidirectional association between depression and metabolic syndrome: a systematic review and meta-Analysis of epidemiological studies. Diabetes Care 35:1171-1180.
143. Pandey GN, Ren X, Rizavi HS, Zhang H (2015). Abnormal gene expression of proinflammatory cytokines and their receptors in the lymphocytes of patients with bipolar disorder. Bipolar Disord 17:636-644.
144. Panek M, Pietras T, Szemraj J, Kuna P (2014). Association analysis of the glucocorticoid receptor gene (NR3C1) haplotypes (ER22/23EK, N363S, BclI) with mood and anxiety disorders in patients with asthma. Exp Ther Med 8:662-670.
145. Papanastasiou E (2013). The prevalence and mechanisms of metabolic syndrome in schizophrenia: a review. Ther Adv Psychopharmacol 3:33-51.
146. Perry VH (2004). The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease. Brain Behav Immun 18:407-413.
147. Petra AI, Panagiotidou S, Hatziagelaki E, Stewart JM, Conti P, Theoharides TC (2015). Gut-microbiota-brain axis and its effect on neuropsychiatric disorders with suspected immune dysregulation. Clin Ther 37:984-995.
148. Phillips CM, Goumidi L, Bertrais S, Ferguson JF, Field MR, Kelly ED, et al. (2010). Additive effect of polymorphisms in the IL-6, LTA, and TNF-(alpha) genes and plasma fatty acid level modulate risk for the metabolic syndrome and its components. J Clin Endocrinol Metab 95:1386-1394.
149. Pola R, Flex A, Gaetani E, Lago AD, Gerardino L, Pola P, Bernabei R (2002). The-174G/C polymorphism of the interleukin-6 gene promoter is associated with Alzheimer's disease in an Italian population [corrected]. Neuroreport 13:1645-1647.
150. Prather AA, Vogelzangs N, Penninx BW (2015). Sleep duration, insomnia, and markers of systemic inflammation: results from the Netherlands Study of Depression and Anxiety (NESDA). J Psychiatr Res 60:95-102.
151. Raab PA, Mackintosh MA, Gros DF, Morland LA (2015). Impact of comorbid depression on quality of life in male combat Veterans with posttraumatic stress disorder. J Rehabil Res Dev 52:563-576.
152. Rachal Pugh C, Fleshner M, Watkins LR, Maier SF, Rudy JW (2001). The immune system and memory consolidation: a role for the cytokine IL-1beta. Neurosci Biobehav Rev 25:29-41.
153. Raedler TJ (2011). Inflammatory mechanisms in major depressive disorder. Curr Opin Psychiatry 24:519-525.
154. Rai NK, Goyal V, Kumar N, Shukla G, Srivastava AK, Singh S, Behari M (2015). Neuropsychiatric co-morbidities in non-demented Parkinson's disease. Ann Indian Acad Neurol 18:33-38.
155. Raison CL, Capuron L, Miller AH (2006). Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 27:24-31.
156. Rao NP, Venkatasubramanian G, Ravi V, Kalmady S, Cherian A, YC JR (2015). Plasma cytokine abnormalities in drug-naïve, comorbidity-free obsessive-compulsive disorder. Psychiatry Res 229:949-952.
157. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB (2010). Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 49:1603-1616.
158. Rhen T, Cidlowski JA (2005). Antiinflammatory action of glucocorticoids-new mechanisms for old drugs. N Engl J Med 353:1711-1723.
159. Ritchie SA, Connell JM (2007). The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis 17:319-326.
160. Rojas SM, Bujarski S, Babson KA, Dutton CE, Feldner MT (2014). Understanding PTSD comorbidity and suicidal behavior: associations among histories of alcohol dependence, major depressive disorder, and suicidal ideation and attempts. J Anxiety Disord 28:318-325.
161. Round JL, Mazmanian SK (2009). The gut microbiome shapes intestinal immune responses during health and disease. Nat Rev Immunol 9:313-323.
162. Saetre P, Emilsson L, Axelsson E, Kreuger J, Lindholm E, Jazin E (2007). Inflammation-related genes up-regulated in schizophrenia brains. BMC Psychiatry 7:46.
163. Salmenniemi U, Ruotsalainen E, Pihlajamäki J, Vauhkonen I, Kainulainen S, Punnonen K, et al. (2004). Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome. Circulation 110:3842-3848.
164. Samuelson KW (2011). Post-traumatic stress disorder and declarative memory functioning: a review. Dialogues Clin Neurosci 13:346-351.
165. Sarapas C, Cai G, Bierer LM, Golier JA, Galea S, Ising M, et al. (2011). Genetic markers for PTSD risk and resilience among survivors of the World Trade Center attacks. Dis Markers 30:101-110.
166. Sartor CE, McCutcheon VV, Pommer NE, Nelson EC, Grant JD, Duncan AE, et al. (2011). Common genetic and environmental contributions to post-traumatic stress disorder and alcohol dependence in young women. Psychol Med 41:1497-1505.
167. Savitz J, Frank MB, Victor T, Bebak M, Marino JH, Bellgowan PS, et al. (2013). Inflammation and neurological disease-related genes are differentially expressed in depressed patients with mood disorders and correlate with morphometric and functional imaging abnormalities. Brain Behav Immun 31:161-171.
168. Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S (2011). The pro-And antiinflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta 1813:878-888.
169. Schmahl C, Arvastson L, Tamm JA, Bohus M, Abdourahman A, Antonijevic I (2013). Gene expression profiles in relation to tension and dissociation in borderline personality disorder. PLoS One 8:e70787.
170. Segman RH, Shefi N, Goltser-Dubner T, Friedman N, Kaminski N, Shalev AY (2005). Peripheral blood mononuclear cell gene expression profiles identify emergent post-traumatic stress disorder among trauma survivors. Mol Psychiatry 10:500-513.
171. Shibata N, Ohnuma T, Takahashi T, Baba H, Ishizuka T, Ohtsuka M, et al. (2002). Effect of IL-6 polymorphism on risk of Alzheimer disease: genotype-phenotype association study in Japanese cases. Am J Med Genet 114:436-439.
172. Simon NM, McNamara K, Chow CW, Maser RS, Papakostas GI, Pollack MH, et al. (2008). A detailed examination of cytokine abnormalities in major depressive disorder. Eur Neuropsychopharmacol 18:230-233.
173. Sinclair D, Fullerton JM,Webster MJ, ShannonWeickert C (2012). Glucocorticoid receptor 1B and 1C mRNA transcript alterations in schizophrenia and bipolar disorder, and their possible regulation by GR gene variants. PLoS One 7: e31720.
174. Sinclair D, Fillman SG, Webster MJ, Weickert CS (2013). Dysregulation of glucocorticoid receptor co-factors FKBP5, BAG1 and PTGES3 in prefrontal cortex in psychotic illness. Sci Rep 3:3539.
175. Slavich GM, Irwin MR (2014). From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychol Bull 140:774-815.
176. Sobti RC, Kler R, Sharma YP, Talwar KK, Singh N (2012). Risk of obesity and type 2 diabetes with tumor necrosis factor-A 308G/A gene polymorphism in metabolic syndrome and coronary artery disease subjects. Mol Cell Biochem 360:1-7.
177. Spijker AT, van Rossum EF, Hoencamp E, DeRijk RH, Haffmans J, Blom M, et al. (2009). Functional polymorphism of the glucocorticoid receptor gene associates with mania and hypomania in bipolar disorder. Bipolar Disord 11:95-101.
178. Spinhoven P, Penninx BW, van Hemert AM, de Rooij M, Elzinga BM (2014). Comorbidity of PTSD in anxiety and depressive disorders: prevalence and shared risk factors. Child Abuse Negl 38:1320-1330.
179. Spitzer C, Barnow S, Völzke H, Wallaschofski H, John U, Freyberger HJ, et al. (2010). Association of posttraumatic stress disorder with low-grade elevation of C-reactive protein: evidence from the general population. J Psychiatr Res 44:15-21.
180. Starkman MN, Cameron OG, Nesse RM, Zelnik T (1990). Peripheral catecholamine levels and the symptoms of anxiety: studies in patients with and without pheochromocytoma. Psychosom Med 52:129-142.
181. Stein MB, Jang KL, Taylor S, Vernon PA, Livesley WJ (2002). Genetic and environmental influences on trauma exposure and posttraumatic stress disorder symptoms: a twin study. Am J Psychiatry 159:1675-1681.
182. Szabó C, Kelemen O, Kéri S (2014). Changes in FKBP5 expression and memory functions during cognitive-behavioral therapy in posttraumatic stress disorder: a preliminary study. Neurosci Lett 569:116-120.
183. Szczepankiewicz A, Leszczynska-Rodziewicz A, Pawlak J, Rajewska-Rager A, Dmitrzak-Weglarz M, Wilkosc M, et al. (2011). Glucocorticoid receptor polymorphism is associated with major depression and predominance of depression in the course of bipolar disorder. J Affect Disord 134:138-144.
184. Szczepankiewicz A, Leszczynska-Rodziewicz A, Pawlak J, Narozna B, Rajewska-Rager A, Wilkosc M, et al. (2014). FKBP5 polymorphism is associated with major depression but not with bipolar disorder. J Affect Disord 164:33-37.
185. Tambuyzer BR, Ponsaerts P, Nouwen EJ (2009). Microglia: gatekeepers of central nervous system immunology. J Leukoc Biol 85:352-370.
186. Taylor JM, Minter MR, Newman AG, Zhang M, Adlard PA, Crack PJ (2014). Type-1 interferon signaling mediates neuro-inflammatory events in models of Alzheimer's disease. Neurobiol Aging 35:1012-1023.
187. Teixeira AA, Quinto BMR, Dalboni MA, de Oliveira Rodrigues CJ, Batista MC (2015). Association of IL-6 polymorphism-174G/C and metabolic syndrome in hypertensive patients. BioMed Res Int 2015; 2015:927589.
188. Traks T, Koido K, Balõtšev R, Eller T, Kõks S, Maron E, et al. (2015). Polymorphisms of IKBKE gene are associated with major depressive disorder and panic disorder. Brain Behav 5:e00314.
189. True WR, Rice J, Eisen SA, Heath AC, Goldberg J, Lyons MJ, Nowak J (1993). A twin study of genetic and environmental contributions to liability for posttraumatic stress symptoms. Arch Gen Psychiatry 50:257-264.
190. Tsao CW, Lin YS, Chen CC, Bai CH, Wu SR (2006). Cytokines and serotonin transporter in patients with major depression. Prog Neuropsychopharmacol Biol Psychiatry 30:899-905.
191. Tükel R, Arslan BA, Ertekin BA, Ertekin E, Oflaz S, Ergen A, et al. (2012). Decreased IFN-? and IL-12 levels in panic disorder. J Psychosom Res 73:63-67.
192. Uddin M, Aiello AE, Wildman DE, Koenen KC, Pawelec G, de Los Santos R, et al. (2010). Epigenetic and immune function profiles associated with posttraumatic stress disorder. Proc Natl Acad Sci USA 107:9470-9475.
193. Van Rossum EFC, Binder EB, Majer M, Koper JW, Ising M, Modell S, et al. (2006). Polymorphisms of the glucocorticoid receptor gene and major depression. Biol Psychiatry 59:681-688.
194. Van West D, van Den Eede F, Del-Favero J, Souery D, Norrback KF, van Duijn C, et al. (2006). Glucocorticoid receptor gene-based SNP analysis in patients with recurrent major depression. Neuropsychopharmacology 31:620-627.
195. Van Zuiden M, Geuze E, Willemen HL, Vermetten E, Maas M, Amarouchi K, et al. (2012). Glucocorticoid receptor pathway components predict posttraumatic stress disorder symptom development: a prospective study. Biol Psychiatry 71:309-316.
196. Violanti JM, Fekedulegn D, Hartley TA, Andrew ME, Charles LE, Mnatsakanova A, Burchfiel CM (2006). Police trauma and cardiovascular disease: association between PTSD symptoms and metabolic syndrome. Int J Emerg Ment Health 8:227-237.
197. Von Känel R, Hepp U, Kraemer B, Traber R, Keel M, Mica L, Schnyder U (2007). Evidence for low-grade systemic proinflammatory activity in patients with posttraumatic stress disorder. J Psychiatr Res 41:744-752.
198. Wang Y, Hancock AM, Bradner J, Chung KA, Quinn JF, Peskind ER, et al. (2011). Complement 3 and factor h in human cerebrospinal fluid in Parkinson's disease, Alzheimer's disease, and multiple-system atrophy. Am J Pathol 178:1509-1516.
199. Wang J, Wu Z, Li D, Li N, Dindot SV, Satterfield MC, et al. (2012). Nutrition, epigenetics, and metabolic syndrome. Antioxid Redox Signal 17:282-301.
200. Wärnberg J, Marcos A (2008). Low-grade inflammation and the metabolic syndrome in children and adolescents. Curr Opin Lipidol 19:11-15.
201. Weiss T, Skelton K, Phifer J, Jovanovic T, Gillespie CF, Smith A, et al. (2011). Posttraumatic stress disorder is a risk factor for metabolic syndrome in an impoverished urban population. Gen Hosp Psychiatry 33:135-142.
202. Wieck A, Grassi-Oliveira R, do Prado CH, Viola TW, Petersen LE, Porto B, et al. (2016). Toll-like receptor expression and function in type I bipolar disorder. Brain Behav Immun 54:110-121.
203. Williamson LL, Sholar PW, Mistry RS, Smith SH, Bilbo SD (2011). Microglia and memory: modulation by early-life infection. J Neurosci 31:15511-15521.
204. Wilson CB, McLaughlin LD, Nair A, Ebenezer PJ, Dange R, Francis J (2013). Inflammation and oxidative stress are elevated in the brain, blood, and adrenal glands during the progression of post-traumatic stress disorder in a predator exposure animal model. PLoS One 8:e76146.
205. Wu HJ, Wu E (2012). The role of gut microbiota in immune homeostasis and autoimmunity. Gut Microbes 3:4-14.
206. Wu YR, Chen CM, Hwang JC, Chen ST, Feng IH, Hsu HC, et al. (2007a). Interleukin-1 alpha polymorphism has influence on late-onset sporadic Parkinson's disease in Taiwan. J Neural Transm (Vienna) 114:1173-1177.
207. Wu YR, Feng IH, Lyu RK, Chang KH, Lin YY, Chan H, et al. (2007b). Tumor necrosis factor-Alpha promoter polymorphism is associated with the risk of Parkinson's disease. Am J Med Genet B Neuropsychiatr Genet 144B:300-304.
208. Xie P, Kranzler HR, Poling J, Stein MB, Anton RF, Farrer LA, Gelernter J (2010). Interaction of FKBP5 with childhood adversity on risk for post-traumatic stress disorder. Neuropsychopharmacology 35:1684-1692.
209. Xie P, Kranzler HR, Yang C, Zhao H, Farrer LA, Gelernter J (2013). Genome-wide association study identifies new susceptibility loci for posttraumatic stress disorder. Biol Psychiatry 74:656-663.
210. Yaffe K, Vittinghoff E, Lindquist K, Barnes D, Covinsky KE, Neylan T, et al. (2010). Post-traumatic stress disorder and risk of dementia among U.S. Veterans. Arch Gen Psychiatry 67:608-613.
211. Yan YX, Dong J, Zhang J, Liu F, Wang W, Zhang L, He Y (2014). Polymorphisms in NR3C1 gene associated with risk of metabolic syndrome in a Chinese population. Endocrine 47:740-748.
212. Yehuda R, Golier JA, Yang RK, Tischler L (2004). Enhanced sensitivity to glucocorticoids in peripheral mononuclear leukocytes in posttraumatic stress disorder. Biol Psychiatry 55:1110-1116.
213. Yehuda R, Cai G, Golier JA, Sarapas C, Galea S, Ising M, et al. (2009). Gene expression patterns associated with posttraumatic stress disorder following exposure to the World Trade Center attacks. Biol Psychiatry 66:708-711.
214. Yirmiya R, Goshen I (2011). Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav Immun 25:181-213.
215. Young EA, Breslau N (2004). Cortisol and catecholamines in posttraumatic stress disorder: an epidemiologic community study. Arch Gen Psychiatry 61:394-401.
216. Yu YWY, Chen TJ, Hong CJ, Chen HM, Tsai SJ (2003). Association study of the interleukin-1 beta (C-511 T) genetic polymorphism with major depressive disorder, associated symptomatology, and antidepressant response. Neuropsychopharmacol 28:1182-1185.
217. Zalli A, Jovanova O, Hoogendijk WJ, Tiemeier H, Carvalho LA (2016). Low-grade inflammation predicts persistence of depressive symptoms. Psychopharmacology (Berl) 233:1669-1678.
218. Zhang Y, Hayes A, Pritchard A, Thaker U, Haque MS, Lemmon H, et al. (2004). Interleukin-6 promoter polymorphism: risk and pathology of Alzheimer's disease. Neurosci Lett 362:99-102.
219. Zieker J, Zieker D, Jatzko A, Dietzsch J, Nieselt K, Schmitt A, et al. (2007). Differential gene expression in peripheral blood of patients suffering from post-traumatic stress disorder. Mol Psychiatry 12:116-118.
220. Zobel A, Jessen F, von Widdern O, Schuhmacher A, Höfels S, Metten M, et al. (2008). Unipolar depression and hippocampal volume: impact of DNA sequence variants of the glucocorticoid receptor gene. Am J Med Genet B Neuropsychiatr Genet 147B:836-843.
221. Zoladz PR, Fleshner M, Diamond DM (2012). Psychosocial animal model of PTSD produces a long-lasting traumatic memory, an increase in general anxiety and PTSD-like glucocorticoid abnormalities. Psychoneuroendocrinology 37: 1531-1545.